Cofactor Genomics, the developer of advanced RNA analysis tools, has announced that it has entered into an agreement with the National Cancer Institute, to demonstrate the clinical utility of its immune-profiling assay, Cofactor Paragon.
A new promising drug that could prove an effective treatment for breast cancer patients who have proved unresponsive to hormone therapy, has entered human trials.
Researchers have developed a test that provides a safe and minimally invasive method for earlier diagnosis of ovarian and endometrial cancers.
Head of the FDA, Scott Gottlieb has suggested some ways in which pharma giants could rethink their business models, to help unproductive drugmakers.
A new study has identified two genes associated with hyperemesis gravidarum, a condition that causes severe nausea and vomiting during pregnancy.
There is a disconnect between scientists and the public when it comes to genomics. What is the public’s understanding of genomics and why is this important?
New research suggests that many people’s health problems brought on by single-gene mutations are getting misdiagnosed.
Color’s new DNA test identifies inherited heart conditions, where the idea is for customers to work with their doctor to come up with a plan to detect conditions early and prevent medical problems.
Chinese pharmaceutical companies are proving their place in the US generic drugs market, with a rising number of approvals for copycat medicines almost doubling in the past year.
For the first time, researchers have been able to use long read nanopore sequencing to assemble the genomic sequence of a human Y chromosome centromere.